A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities
Open Access
- 11 November 2019
- journal article
- review article
- Published by Springer Nature in BMC Public Health
- Vol. 19 (1) , 1-32
Abstract
Background: Bacille Calmette-Guérin (BCG) vaccination against tuberculosis (TB) is widespread in high-TB-burden countries, however, BCG vaccination policies in low-burden countries vary. Considering the uncertainties surrounding BCG efficacy and the lower likelihood of TB exposure in low-incidence countries, most have discontinued mass vaccination, choosing instead a targeted vaccination strategy among high-risk groups. Given the increased risk of TB infection in Canadian Indigenous communities compared to the general Canadian population, these communities are a pertinent example of high-incidence groups in an otherwise low-burden country, warranting particular consideration regarding BCG vaccination strategy. This systematic review aims to synthesise and critically appraise the literature on BCG vaccination strategies in high-risk groups in low-incidence settings to provide policy considerations relevant to the Canadian Indigenous context.Methods:A literature search of the Medline and Embase databases was conducted, returning studies pertaining to BCG vaccine efficacy, TB incidence under specific vaccination policies, BCG-associated adverse events, and vaccination policy guidelines in low-burden countries. Study screening was tracked using the Covidence systematic review software (Veritas Health Innovation, Melbourne, Australia), and data pertaining to the above points of interest were extracted.Results: The final review included 49 studies, spanning 15 countries. Although almost all of these countries had implemented a form of mass or routine vaccination previously, 11 have since moved to targeted vaccination of selected risk groups, in most cases due to the low risk of infection among the general population and thus the high number of vaccinations needed to prevent one case in the context of low-incidence settings. Regarding identifying risk groups for targeted screening, community-based (rather than individual risk-factor-based) vaccination has been found to be beneficial in high-incidence communities within low-incidence countries, suggesting this approach may be beneficial in the Canadian Indigenous setting.Conclusions: Community-based vaccination of high-incidence communities may be beneficial in the Canadian Indigenous context, however, where BCG vaccination is implemented, delivery strategies and potential barriers to achieving adequate coverage in this setting should be considered. Where an existing vaccination program is discontinued, it is crucial that an effective TB surveillance system is in place, and that case-finding, screening, and diagnostic efforts are strengthened in order to ensure adequate TB control. This is particularly relevant in Canadian Indigenous and other remote or under-served communities, where barriers to surveillance, screening, and diagnosis persist.Keywords
Funding Information
- Indigenous Services Canada
This publication has 62 references indexed in Scilit:
- Controversies and Unresolved Issues in Tuberculosis Prevention and Control: A Low-Burden-Country PerspectiveThe Journal of Infectious Diseases, 2012
- Barriers to implementation of the new targeted BCG vaccination in France: A cross sectional studyVaccine, 2011
- The BCG World Atlas: A Database of Global BCG Vaccination Policies and PracticesPLOS Medicine, 2011
- Tuberculosis in Nunavut: a century of failureCanadian Medical Association Journal, 2011
- Trade-off between BCG vaccination and the ability to detect and treat latent tuberculosisJournal of Theoretical Biology, 2009
- Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settingsVaccine, 2008
- Bacille–Calmette–Guerin vaccination and the development of allergic disease in children: a randomized, prospective, single‐blind studyClinical & Experimental Allergy, 2007
- Tuberculosis: diagnosis, management and preventionArchives of Disease in Childhood - Education & Practice Edition, 2007
- Pros and Cons of BCG Vaccination in Countries with Low Incidence of TuberculosisInfection Control & Hospital Epidemiology, 1994
- Evaluation of BCG at birth in the United Arab EmiratesTubercle, 1990